Comparing Direct Medical Costs of OnabotulinumtoxinA With Other Common Overactive Bladder Interventions.
- Published in:
- American Journal of Pharmacy Benefits, 2018, v. 10, n. 1, p. 11
- By:
- Publication type:
- Article
Works matching IS 19454481 AND DT 2018 AND VI 10 AND IP 1
Results: 6
1
2
Having a Broader Conversation About Healthcare Spending.
- Published in:
- American Journal of Pharmacy Benefits, 2018, v. 10, n. 1, p. 31
- By:
- Publication type:
- Article
3
Where Might CMS Drive the Industry in the Next Few Years?
- Published in:
- American Journal of Pharmacy Benefits, 2018, v. 10, n. 1, p. 9
- By:
- Publication type:
- Article
4
Psoriasis Treatment Cost Comparison: Biologics Versus Home Phototherapy.
- Published in:
- American Journal of Pharmacy Benefits, 2018, v. 10, n. 1, p. 18
- By:
- Publication type:
- Article
5
Predictors of Healthcare Costs After Initiating Dabigatran Versus Warfarin.
- Published in:
- American Journal of Pharmacy Benefits, 2018, v. 10, n. 1, p. 22
- By:
- Publication type:
- Article
6
Clinical and Cost Outcomes of Buprenorphine Treatment in a Commercial Benefit Plan Population.
- Published in:
- American Journal of Pharmacy Benefits, 2018, v. 10, n. 1, p. 84
- By:
- Publication type:
- Article